Validating Well-Functioning Hepatic Organoids for Toxicity Evaluation
Toxics · 17.05.2024 · 12 (5) · 371
DOI: 10.3390/toxics12050371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxics, online erschienen am 17.05.2024. Verfasst von Seo Yoon Choi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Toxicological Research, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Food and Drug Safety.
Abstract (Originalsprache)
“Organoids”, three-dimensional self-organized organ-like miniature tissues, are proposed as intermediary models that bridge the gap between animal and human studies in drug development. Despite recent advancements in organoid model development, studies on toxicity using these models are limited. Therefore, in this study, we aimed to analyze the functionality and gene expression of pre- and post-differentiated human hepatic organoids derived from induced pluripotent stem cells and utilize them for toxicity assessment. First, we confirmed the functional similarity of this hepatic organoid model to the human liver through various functional assessments, such as glycogen storage, albumin and bile acid secretion, and cytochrome P450 (CYP) activity. Subsequently, utilizing these functionally validated hepatic organoids, we conducted toxicity evaluations with three hepatotoxic substances (ketoconazole, troglitazone, and tolcapone), which are well known for causing drug-induced liver injury, and three non-hepatotoxic substances (sucrose, ascorbic acid, and biotin). The organoids effectively distinguished between the toxicity levels of substances with and without hepatic toxicity. We demonstrated the potential of hepatic organoids with validated functionalities and genetic characteristics as promising models for toxicity evaluation by analyzing toxicological changes occurring in hepatoxic drug-treated organoids.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Toxicological Research, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea.
- Department of Orthopaedic Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
- Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
- Division of Pharmacological Drug Research, National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Cheongju 28159, Republic of Korea.
- Department of Functional Genomics, Korea University of Science & Technology (UST), Daejeon 34113, Republic of Korea.
ORCID-Profile: Tae Hee Kim, Seon Ju Mun
Förderung
- Ministry of Food and Drug Safety
Zitieren
APA
Choi, S. Y., Kim, T. H., Kim, M. J., Mun, S. J., Kim, T. S., Jung, K. K., Oh, I. U., Oh, J. H., Son, M. J., & Lee, J. H. (2024). Validating Well-Functioning Hepatic Organoids for Toxicity Evaluation. Toxics, 12(5), 371. https://doi.org/10.3390/toxics12050371
Vancouver
Choi SY, Kim TH, Kim MJ, Mun SJ, Kim TS, Jung KK, et al. Validating Well-Functioning Hepatic Organoids for Toxicity Evaluation. Toxics. 2024;12(5):371. doi:10.3390/toxics12050371
BibTeX
@article{Choi2024,
author = {Choi, Seo Yoon and Kim, Tae Hee and Kim, Min Jeong and Mun, Seon Ju and Kim, Tae Sung and Jung, Ki Kyung and Oh, Il Ung and Oh, Jae Ho and Son, Myung Jin and Lee, Jin Hee},
title = {Validating Well-Functioning Hepatic Organoids for Toxicity Evaluation},
journal = {Toxics},
year = {2024},
volume = {12},
number = {5},
pages = {371},
doi = {10.3390/toxics12050371}
}
EUVIMED